|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 19.68 USD | -4.00% |
|
-3.72% | +11.56% |
| 06-30 | Zai Lab Insider Sold Shares Worth $428,545, According to a Recent SEC Filing | MT |
| 06-16 | Zai Lab Receives EU Orphan Drug Designation for Lung Cancer Drug | MT |
Main competitors
| Dividend Yield (Y) | Dividend Yield (Y+1) | P/E (Y) | Price to Book (Y) | EV / Sales (Y) | EV / EBITDA (Y) | EV / EBIT (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|
| -.--% | -.--% | -9.26x | 4.31x | 4.15x | -7.66x | -7.19x | 2.3B | ||
| 0.6% | 0.68% | 17.15x | 1.95x | 3.68x | 9.49x | 10.99x | 66.25B | ||
| 0.6% | 0.62% | 26.07x | 3.94x | 5.39x | 15.85x | 19.65x | 52.86B | ||
| -.--% | -.--% | 33.98x | 6.82x | 11.48x | 21.98x | 25.6x | 43.01B | ||
| 3.45% | 3.55% | -44.33x | 2.45x | 3.15x | 9.3x | 10.85x | 39.52B | ||
| -.--% | -.--% | 24.04x | 1.57x | 3.43x | 11.65x | 13.51x | 29.19B | ||
| -.--% | -.--% | 55.87x | 3.3x | 3.21x | 26.87x | 27.24x | 23.13B | ||
| -.--% | -.--% | -6.71x | 4.07x | 9.37x | -5.77x | -5.4x | 23.04B | ||
| -.--% | 0.05% | 66.64x | 5.99x | 6.57x | 45.21x | 51x | 20.48B | ||
| -.--% | -.--% | 24.35x | 3.57x | 5.21x | 13.64x | 18.86x | 16.6B | ||
| -.--% | -.--% | -37.32x | -6.59x | 17.71x | -48.48x | -56.03x | 16.2B | ||
| -.--% | -.--% | -116.24x | 12691.74x | 12.48x | -89.37x | -124.56x | 12.33B | ||
| -.--% | -.--% | 17.31x | - | 3.56x | 13.78x | 16.09x | 11.29B | ||
| -.--% | -.--% | 45.1x | - | - | - | - | 9.93B | ||
| 0.19% | 0.2% | 49.03x | 19.99x | 29.56x | 41.81x | 43.12x | 9.72B | ||
| 2.66% | 3.05% | 12.85x | 1.15x | 1.86x | 7.49x | 10.13x | 6.74B | ||
| 0.35% | 0.41% | 29.13x | - | 7.85x | 20.82x | 24.86x | 5.95B | ||
| 1.64% | 1.82% | 13.95x | 1.26x | 2.39x | 6.25x | 7.55x | 5.51B | ||
| Average | 0.53% | 0.58% | 11.20x | 849.70x | 7.71x | 5.46x | 5.07x | 21.89B | |
| Weighted average by Cap. | 0.61% | 0.65% | 13.27x | 429.92x | 6.79x | 9.44x | 10.29x |
- Stock Market
- Stocks
- ZLAB Stock
- Sector Zai Lab Limited
- Sector dividends
Select your edition
All financial news and data tailored to specific country editions
















